QSS
VIRX

Quantitative Systematic Strategies’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Quantitative Systematic Strategies’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,588
Closed -$305K – 949
2015
Q3 		$305K Buy
1,588
+1,267
+395% +$457K 0.15% 294
2015
Q2 		$196K Sell
321
-456
-59% -$242K 0.04% 477
2015
Q1 		$400K Buy
+777
New +$392K 0.11% 279
2014
Q4 		– Sell
-512
Closed -$803K – 439
2014
Q3 		$803K Buy
+512
New +$741K 0.47% 68

Other funds holding VIRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quantitative Systematic Strategies's VIRX Position: Q4 2015 in Review

Quantitative Systematic Strategies sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q4 2015, closing a stake of 1,588 shares — an estimated $305K sold.

Quantitative Systematic Strategies first reported a position in VIRX in Q3 2014 and held it in 4 quarters. The position peaked at $803K in Q3 2014. 55 funds tracked by Wall St. Rank hold VIRX as of Q4 2015.

  • Quantitative Systematic Strategies reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,588 Viracta Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $305K.
  • Quantitative Systematic Strategies first reported a position in Viracta Therapeutics, Inc. Common Stock in Q3 2014 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Viracta Therapeutics, Inc. Common Stock position peaked at $803K in Q3 2014.
  • 55 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2015, filed 13 Jan 2016.